Phreesia, Inc. (PHR) SEC Filings & Earnings Calls
EquiReason read 20 Phreesia, Inc. SEC filings in the last 12 months. Latest: 10-Q on 2026-09-03 — Phreesia reported Q2 FY2027 results: revenue +10%, net income $1.9M vs $0.7M, Adjusted EBITDA +49%, free cash flow +44%, with restructuring plan underway..
Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason
- Market cap
- 788.3M
- P/E TTM
- 74.7
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 7 Dec, in 44 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
3 Sep 202610-QPhreesia reported Q2 FY2027 results: revenue +10%, net income $1.9M vs $0.7M, Adjusted EBITDA +49%, free cash flow +44%, with restructuring plan underway.earningsopen
Figures in the filing · each found in the filing text
| Total Revenue · Q2-2027 | $129M | +10% y/y |
| Adjusted EBITDA · Q2-2027 | $33M | +49% y/y |
| Free Cash Flow · Q2-2027 | $14M | +44% y/y |
| Operating Cash Flow · Q2-2027 | $18M | +24% y/y |
| Average Number of Healthcare Services Clients (AHSCs) · Q2-2027 | 4,744 | +6% y/y |
| Total Revenue per AHSC · Q2-2027 | $27289.00 | +4% y/y |
| Total Managed Payments · Q2-2027 | $1.63B | |
| Payment Solutions Revenue Rate · Q2-2027 | 2.4% | |
| Cash and Equivalents · Q2-2027 | $75M | |
| Subscription and Related Services Revenue · Subscription and related services · Q2-2027 | $53M | -2% y/y |
Risks flagged
Subscription Revenue Decline
“Subscription and related services revenue from healthcare services organizations decreased $1.0 million to $52.7 million for the three months ended July 31, 2026, as compared to $53.7 million for the three months ended July 31, 2025” · word for word
Restructuring Execution Risk
“The Plan includes the elimination of approximately 220 positions, approximately half of which are contractor roles.” · word for word
AI Investment Pressure
“the pace of AI innovation across the industry may require us to accelerate these investments, which could increase our research and development expenses as a percentage of revenue in future periods.” · word for word
2 Sep 20268-K · 2.02Q2 FY27 revenue $129.5M (+10% YoY), net income $1.9M (vs $0.7M), adjusted EBITDA $32.9M (vs $22.1M). Free cash flow positive. Guidance maintained. Restructuring plan underway with $10M charges.open
Figures in the filing · each found in the filing text
| Total revenue · Q2-2027 | $130M | +10% y/y |
| Average number of healthcare services clients · Q2-2027 | 4,744 | +6% y/y |
| Total revenue per AHSC · Q2-2027 | $27289.00 | +4% y/y |
| Net income · Q2-2027 | $2M | +171% y/y |
| Adjusted EBITDA · Q2-2027 | $33M | +49% y/y |
| Free cash flow · Q2-2027 | $14M | +44% y/y |
| Cash, cash equivalents and restricted cash · Q2-2027 | $75M |
Guidance
FY27 revenue $510M-$520M, adjusted EBITDA $125M-$135M
Guidance maintained; profitability improving with restructuring benefits.
Risks flagged
Restructuring plan may cause short-term disruption, but expected to reduce costs.
“Restructuring charges of approximately $2.8M recognized in Q2; total expected ~$10M”
Variability in network solutions revenue forecasting, especially in H2.
“There is now more variability in our network solutions revenue forecasting, particularly in the second half of each fiscal year” · word for word
28 May 202610-QRevenue $131M (+13% y/y); Segment Net Income (Loss) $3M (+176% y/y); Labor Costs (excl. SBC) $46M (-7% y/y)open
Figures in the filing · each found in the filing text
| Revenue · Q1-2027 | $131M | +13% y/y |
| Segment Net Income (Loss) · Q1-2027 | $3M | +176% y/y |
| Labor Costs (excl. SBC) · Q1-2027 | $46M | -7% y/y |
| Payment Solutions Expense · Q1-2027 | $26M | +20% y/y |
| Stock-Based Compensation · Q1-2027 | $14M | -21% y/y |
| Depreciation and Amortization · Q1-2027 | $10M | +45% y/y |
| Expenditures for Long-Lived Assets · Q1-2027 | $8M | +7% y/y |
| Deferred Purchase Price Receivable · Q1-2027 | $30M |
Risks flagged
Restructuring Execution Risk
“Completion of the restructuring plan may have continuing adverse effects on our workforce, including negative effects on employee morale, increased employee attrition, increased difficulty in hiring new employees, and diversion of management attention.” · word for word
Cybersecurity Incident Risk
“For example, in 2024, we experienced a cybersecurity incident which impacted our ConnectOnCall product.” · word for word
Client Concentration Risk
“We historically derive a significant portion of our revenues from our largest clients.” · word for word
Regulatory and Policy Risk
“Changes in healthcare, utilization and spending trends, including as a result of changes to healthcare policy and the One Big Beautiful Bill Act.” · word for word
27 May 20268-K · 2.02Total revenue $131M (+13% y/y); Average number of healthcare services clients (AHSCs) 4,708 (+7% y/y); Total revenue per AHSC $27,811.00 (+6% y/y); Guidance: FY27 revenue outlook maintained at $510-520Mearningsopen
Figures in the filing · each found in the filing text
| Total revenue · Q1-2027 | $131M | +13% y/y |
| Average number of healthcare services clients (AHSCs) · Q1-2027 | 4,708 | +7% y/y |
| Total revenue per AHSC · Q1-2027 | $27811.00 | +6% y/y |
| Net income · Q1-2027 | $3M | |
| Adjusted EBITDA · Q1-2027 | $31M | +47% y/y |
| Free cash flow · Q1-2027 | $16M | +119% y/y |
| Cash, cash equivalents and restricted cash · Q1-2027 | $76M |
Guidance
FY27 revenue outlook maintained at $510-520M
Phreesia maintained FY27 revenue guidance, noting H2 network solutions variability but overall positive momentum with profitability improvement.
Risks flagged
Network solutions revenue variability: Clients committing lower spend for H2 FY27 due to brand-specific dynamics and regulatory policies, creating forecasting uncertainty.
“network solutions clients are committing lower spend levels for the second half of fiscal 2027 than we had anticipated last December. Certain clients are committing fewer dollars due to brand-specific dynamics including the impact of regulatory policies.” · word for word
AccessOne securitization facility expansion increases leverage: Facility limit increased from $200M to $300M, with Phreesia becoming co-guarantor, increasing contingent liability.
“The Amendment extended the term of the Securitization Program through April 30, 2029 and increased the facility limit from $200 million to $300 million... Phreesia became a joint and several co-guarantor.” · word for word
14 May 2026DEF 14AProxy statement for annual meeting; discloses executive compensation structure and strong financial performance.open
Figures in the filing · each found in the filing text
| Revenue · FY2026 | $481M | +14% y/y |
| Net Income · FY2026 | $2M | |
| Adjusted EBITDA · FY2026 | $102M | |
| Free Cash Flow · FY2026 | $57M | |
| Operating Cash Flow · FY2026 | $81M | |
| Average Healthcare Services Clients (AHSCs) · FY2026 | 4,514 | +7% y/y |
| Revenue per AHSC · FY2026 | $106467.00 | +7% y/y |
Guidance
FY2026 revenue target $472M; Adjusted EBITDA target $88M (top end of initial outlook)
Compensation targets indicate management expected strong growth; actual results exceeded targets.
Risks flagged
Concentration Risk
“No explicit concentration risk disclosed.”
Cybersecurity Risk
“Standard risk factor for healthcare technology companies.”
11 May 20268-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement)open
Guidance
Restructuring savings already embedded in FY27 Adjusted EBITDA outlook; implies margin expansion.
Risks flagged
Actual costs and savings may differ materially from expectations; additional unanticipated costs may arise.
“The Company’s expectations regarding costs and savings in connection with the plan are subject to assumptions, and actual amounts may differ materially from these expectations. The Company may also incur costs not currently contemplated.”
3 Apr 20268-K · 2.02Adjusted EBITDA $100M; Free cash flow $50Mearningsopen
Figures in the filing · each found in the filing text
| Adjusted EBITDA · FY2026 | $100M | |
| Free cash flow · FY2026 | $50M |
Risks flagged
Execution risk on AccessOne capital expansion and ProviderConnect adoption
“Actively working to expand access to capital for securitization programs; ProviderConnect is a new offering”
31 Mar 202610-KNet Income $2M; Operating Loss $7M; Patient Visits 180,000,000open
Figures in the filing · each found in the filing text
| Net Income · FY2026 | $2M | |
| Operating Loss · FY2026 | $7M | |
| Patient Visits · FY2026 | 180,000,000 |
Risks flagged
Cybersecurity Incident Risk
“In 2024, we experienced a cybersecurity incident which impacted our ConnectOnCall product.” · word for word
Competition from EHR Systems
“Some of these EHR and PM systems offer, or may begin to offer, services, including patient intake and engagement services, payment processing tools, patient financing options and direct patient communication services, in the same or similar manner as we do.” · word for word
Client Concentration
“Historically, we have relied on a limited number of clients for a substantial portion of our total revenue and accounts receivable.” · word for word
30 Mar 20268-K · 2.02Total revenue $127M (+16% y/y); Average number of healthcare services clients (AHSCs) 4,658 (+7% y/y); Total revenue per AHSC $27,279.00 (+8% y/y); Guidance: Revenue guidance lowered from $545-559M to $510-520M for FY2027earningsopen
Figures in the filing · each found in the filing text
| Total revenue · Q4-2026 | $127M | +16% y/y |
| Average number of healthcare services clients (AHSCs) · Q4-2026 | 4,658 | +7% y/y |
| Total revenue per AHSC · Q4-2026 | $27279.00 | +8% y/y |
| Net income · Q4-2026 | $1M | |
| Adjusted EBITDA · Q4-2026 | $29M | +79% y/y |
| Free cash flow · Q4-2026 | $29M | +210% y/y |
| Cash, cash equivalents and restricted cash · 2026-01-31 | $74M | -12% y/y |
Guidance
Revenue guidance lowered from $545-559M to $510-520M for FY2027
Revenue guidance cut due to pharma spending visibility, but strong margin and cash flow performance provide offset.
Risks flagged
Revenue visibility risk from pharmaceutical manufacturer spending commitments
“We are experiencing shorter visibility into spending commitments by certain pharmaceutical manufacturers.” · word for word
Integration risk from AccessOne acquisition and increased leverage from Bridge Loan
“AccessOne Acquisition for ~$164 million funded with cash and $110 million Bridge Loan.”
19 Mar 2026SC 13D/APale Fire Capital filed an amended Schedule 13D disclosing a 12.7% activist stake in Phreesia, acquired with working capital.open
Figures in the filing · each found in the filing text
| Beneficial Ownership Percentage · 2026-03-17 | 12.7% | |
| Aggregate Purchase Price · 2026-03-17 | $93M |
19 Mar 2026SC 13D/APale Fire Capital filed an amended Schedule 13D disclosing a 12.7% activist stake in Phreesia, acquired with working capital.open
Figures in the filing · each found in the filing text
| Beneficial Ownership Percentage · 2026-03-17 | 12.7% | |
| Aggregate Purchase Price · 2026-03-17 | $93M |
16 Mar 20268-K · 1.01, 1.02, 2.03, 7.01Phreesia refinanced its bridge loan with a new $275M revolving credit facility, repaying $92.2M at closing. Replaces prior facilities, reduces borrowing costs.open
Figures in the filing · each found in the filing text
| Bridge Loan principal · Q4-2026 | $110M | |
| Bridge Loan repayment · Q4-2026 | $20M | |
| New Credit Facility amount · Q1-2027 | $275M | |
| Borrowed amount at closing · Q1-2027 | $92M |
Risks flagged
Refinancing reduces near-term debt maturity risk and improves financial flexibility
“Replaced short-term bridge loan with long-term revolving credit facility; no penalty for termination”
23 Feb 20268-K · 5.02, 7.01Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)open
Risks flagged
Board transition risk
“Two long-standing directors retiring; new director brings relevant experience.”
9 Dec 202510-QPhreesia reported strong Q3 FY2026 results with revenue up 13% YoY, net income of $4.3M vs a loss of $14.4M in the prior year, and record Adjusted EBITDA of $29.1M.earningsopen
Figures in the filing · each found in the filing text
| Total revenue · Q3-2026 | $120M | +13% y/y |
| Adjusted EBITDA · Q3-2026 | $29M | |
| Free cash flow · Q3-2026 | $9M | |
| Operating cash flow · Q3-2026 | $15M | |
| Subscription and related services revenue · Q3-2026 | $55M | +12% y/y |
| Payment processing fees revenue · Q3-2026 | $27M | +11% y/y |
| Network solutions revenue · Q3-2026 | $37M | +14% y/y |
| Average number of healthcare services clients · Q3-2026 | 4,520 | +7% y/y |
| Total revenue per AHSC · Q3-2026 | $26622.00 | +6% y/y |
| Patient payment volume · Q3-2026 | $1.18B | +9% y/y |
Risks flagged
Cybersecurity Incident Litigation
“Between December 24, 2024 and the date of this report, 14 related putative class action complaints were filed against ConnectOnCall.com, LLC and Phreesia, Inc., in the United States District Court for the Eastern District of New York (the “ConnectOnCall Case”).” · word for word
Integration Risk from AccessOne Acquisition
“We may be unable to successfully integrate the business acquired in the AccessOne Acquisition, integration may be more difficult, costly or time consuming than expected, and we may fail to realize all of the anticipated benefits of the AccessOne Acquisition on the anticipated time frame or at all.” · word for word
Bridge Loan Refinancing Risk
“There can be no assurance that our cash from operations and available borrowing capacity will be sufficient to satisfy our obligations under the Bridge Loan, and we may be unable to obtain long-term financing or other alternative financing on favorable terms in a timely manner or at all.” · word for word
8 Dec 20258-K · 2.02Total revenue $120M (+13% y/y); Average number of healthcare services clients (AHSCs) 4,520 (+7% y/y); Total revenue per AHSC $26,622.00 (+6% y/y); Guidance: FY2026 revenue raised to $479-481M from $472-482M; EBITDA raised to $99-101M fromearningsopen
Figures in the filing · each found in the filing text
| Total revenue · Q3-2026 | $120M | +13% y/y |
| Average number of healthcare services clients (AHSCs) · Q3-2026 | 4,520 | +7% y/y |
| Total revenue per AHSC · Q3-2026 | $26622.00 | +6% y/y |
| Net income · Q3-2026 | $4M | |
| Adjusted EBITDA · Q3-2026 | $29M | |
| Free cash flow · Q3-2026 | $9M | |
| Net cash provided by operating activities · Q3-2026 | $16M | |
| Cash and cash equivalents · Q3-2026 | $106M | |
| Revenue guidance FY2026 · FY2026 | $480M | |
| AHSC guidance FY2026 · FY2026 | 4,515 |
Guidance
FY2026 revenue raised to $479-481M from $472-482M; EBITDA raised to $99-101M from $87-92M; FY2027 revenue introduced at $545-559M
Strong execution with raised guidance, profitability inflection, and strategic M&A; management confident in continued growth.
Risks flagged
Integration risk from AccessOne acquisition; $160M cash consideration and new bridge loan increase leverage.
“AccessOne acquisition for $160M funded with cash and $110M secured term loan; integration costs and potential refinancing risk.”
Dependence on healthcare services client growth and retention; AHSC growth of 7% may decelerate.
“AHSCs up 7% YoY; revenue per AHSC up 6% YoY; any slowdown could impact revenue trajectory.”
12 Nov 20258-K · 1.01, 2.01, 2.03Entered a material definitive agreement (acquisition, partnership, or major contract); completed an acquisition or disposition of significant assetsopen
Risks flagged
Integration risk from acquisition
“Completion of AccessOne Acquisition”
Phreesia, Inc. — questions
- What did Phreesia, Inc. file recently?
- 20 SEC filings in the last 12 months. Latest: 10-Q on 2026-09-03 — Phreesia reported Q2 FY2027 results: revenue +10%, net income $1.9M vs $0.7M, Adjusted EBITDA +49%, free cash flow +44%, with restructuring plan underway.
Every figure on this page comes from Phreesia, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.